What is systemic lupus erythematosus (lupus)? Systemic lupus erythematosus (lupus) is a chronic (long-lasting) autoimmune disease that can affect many parts of the body, including the: Skin. Joints. Heart. Lungs. Kidneys. Brain. Lupus happens when the immune system, which normally helps protect the body from infection and disease, attacks its own tissues. This attack causes inflammation and, in some cases, permanent tissue damage. If you have lupus, you may have times of illness (flares) and times of wellness (remission). Lupus flares can be mild to serious, and they do not follow a pattern. However, with treatment, many people with lupus
¿Qué es el lupus eritematoso sistémico (lupus)? El lupus eritematoso sistémico es una enfermedad autoinmunitaria crónica (de larga duración) y que puede afectar muchas partes del cuerpo, tales como: la piel las articulaciones el corazón los pulmones los riñones el cerebro. El lupus ocurre cuando el sistema inmunitario, que normalmente ayuda a proteger al cuerpo contra infecciones y enfermedades, ataca sus propios tejidos. Este ataque causa inflamación y, en algunos casos, daño permanente de los tejidos. Si usted tiene lupus, puede haber momentos en los que está enfermo (brotes) y períodos en que está bien (remisión). Los brotes de lupus
What is scoliosis? Scoliosis is a sideways curve of the spine. Children and teens with scoliosis have an abnormal S-shaped or C-shaped curve of the spine. The curve can happen on either side of the spine and in different places in the spine. With treatment, observation, and follow-up with the doctor, most children and teens with scoliosis have normal, active lives.
Two new studies funded in part by NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) describe efforts to develop stem cell-based approaches for treating Epidermolysis Bullosa (EB), a rare, genetic skin disease. The findings, which were published jointly in the journal, Science Translational Medicine, may lead to individualized therapies for EB, and possibly other genetic diseases. People with EB have skin that is so fragile that the slightest friction causes blisters. The severity of the disease ranges from limited tearing of skin on the hands and feet to widespread blistering and scarring, including mucosal surfaces like the
What is epidermolysis bullosa? Epidermolysis bullosa is a group of rare diseases that cause fragile skin that leads to blisters and tearing. Tears, sores, and blisters in the skin happen when something rubs or bumps the skin. They can appear anywhere on the body. In severe cases, blisters may also develop inside the body. The symptoms of the disease usually begin at birth or during infancy and range from mild to severe.
What is fibrous dysplasia? Fibrous dysplasia happens when abnormal fibrous (scar-like) tissue replaces healthy bone. The fibrous tissue weakens the bone over time, which can lead to: Broken bones. Bones that are misshapen (bowed or crooked). The disease can affect any bone in the body. Some people have no symptoms or only a few symptoms. Other people may have more symptoms. Although there is no cure for fibrous dysplasia, treatments may help to lessen pain, and physical therapy may help strengthen muscle and improve movement.
Lupus Ban Đỏ Hệ Thống (lupus) là gì? Lupus ban đỏ hệ thống (lupus) là một bệnh tự miễn mạn tính (kéo dài) có thể ảnh hưởng đến nhiều bộ phận của cơ thể, bao gồm: Da. Khớp. Tim. Phổi. Thận. Não. Lupus xảy ra khi hệ miễn dịch, mà thường giúp bảo vệ cơ thể khỏi nhiễm trùng và bệnh tật, tấn công các mô của chính mình. Cuộc tấn công này gây viêm và dẫn đến tổn thương mô vĩnh viễn trong một số trường hợp. Nếu quý vị mắc bệnh lupus, quý vị có thể có khoảng
Same Immune Regulatory Protein Found to Play Instrumental Role in Two Hereditary Autoinflammatory Diseases
Research funded in part by the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) has revealed a new role for A20, a protein that regulates a key immune response pathway, in certain early-onset autoinflammatory diseases. The results suggest that targeting this pathway could be an effective strategy for treating these diseases, and possibly related conditions, as well.
The AMP RA/SLE Program brings together the NIH and medical community to address rheumatoid arthritis and lupus with diagnostic and drug advancements.